MedTrace Logo

Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study

NCT01114373 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-02-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test the effect of oral melatonin supplementation (24 mg per night for 4 weeks) on nighttime blood pressure in African Americans with a history of elevated nighttime blood pressure.

Conditions

Interventions

DRUG

Melatonin

Melatonin (N-acetyl-5-methoxytryptamine) is an indoleamine compound. Subjects will receive 24mg of time release melatonin pills (3 x 8mg) to be taken orally at night for 4 weeks.

DRUG

Placebo

Subjects will receive placebo pills (3 pills) to be taken orally once per night for 4 weeks.

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Emory University

    lead OTHER

Principal Investigators

  • Frederic F Rahbari-Oskoui, MD, MSCR · Emory University

  • Arlene Chapman, M.D. · Emory University

  • Donald Bliwise, Ph.D. · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2013-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01114373 on ClinicalTrials.gov